Fig. 7

Infusion concerns before and after eptinezumab treatment (A) and convenience of treatment through infusion (B)

Percentages may not add up to 100% due to rounding. Patients were instructed: “Please rate how much you agree or disagree with the following statements by placing a checkmark ✓ in the column which most closely fits your opinion.” (A) I had concerns about receiving infusions; choices included: extremely concerned, very concerned, moderately concerned, slightly concerned, and not at all concerned. (B) I find it convenient to receive my treatment through an infusion; choices included: strongly agree, agree, undecided, disagree, and strongly disagree.